Table 3.

Change in Reservoir Measures since vaccination, N=54 participants and 650 timepoints

	HIV RNAGag		Total HIV DNA		HIV DNA 2LTR		HIV RNATat-Rev
Fixed Effect	Model Coefficient* (95% CI)	p-value	Model Coefficient* (95% CI)	p-value	Model Coefficient* (95% CI)	p-value	Model Coefficient* (95% CI)	p-value
Days from vaccine to visit	−0.002 (−0.006 to 0.002)	0.26	0.001 (−0.002 to 0.003)	0.51	0.001 (−0.002 to 0.004)	0.65	0.002 (−0.002 to 0.006)	0.39
Vaccines
Saline	Reference		Reference		Reference		Reference
Influenza	0.10 (−0.02 to 0.22)	0.12	0.11 (0.01 to 0.21)	0.04	−0.04 (−0.13 to 0.05)	0.41	0.04 (−0.10 to 0.18)	0.55
Pneumococcal	−0.02 (−0.14 to 0.11)	0.80	0.08 (−0.03 to 0.19)	0.13	−0.07 (−0.16 to 0.02)	0.13	<0.001 (−0.140 to 0.141)	1.00
Level of RNA/DNA on day of vaccination°	−0.76 (−0.86 to −0.66)	<.01	−0.32 (−0.41 to −0.24)	<.01	−0.70 (−0.80 to −0.60)	<.01	−0.92 (−1.03 to −0.82)	<.01

^*Coefficients estimated from multivariable, mixed-effects linear regression. Coefficients with p<0.05 imply that effects were different than zero,

^°Corresponds to the day of vaccination for each cycle